The Women in HealthTech Show

The episode contains some substantive points about behavior change psychology (the 'three Cs' framework, small consistent changes over quick fixes, the GLP-1 medication concern) and NHS scaling strategy, but much of the runtime is devoted to biographical narrative, personal anecdotes about triathlons and hiking, and general networking philosophy that operators likely already understand. The density of novel, actionable insights is moderate but diluted by considerable throat-clearing.

“it's really important to provide people with the right type of infrastructure. And that's what we do with, with Holly Health, it's providing them with a really small goal, making sure that they stick to the small approach and track that that is working”

“one of the biggest statistics that we see in our primary care work is reduction of GP appointments because people are self managing so many more elements of their health”

Grace articulates behavior change principles and small-habit frameworks that are well-established in psychology literature (mentioned: decades of research on unsustainability of quick fixes). The 'three Cs' is a repackaging of existing concepts (self-compassion, confidence-building, behavior change). Her insights on VC funding bias and female founder challenges are real but not novel in 2024. The core product positioning - digital health coaching for chronic disease - is solid but not contrarian or first-principles thinking.

“if you do something that's too intense that you can't sustain and it doesn't form an automatic behavior, it is not going to be sustainable. And that's why the vast majority of diets don't result in long term um, change”

“I do worry about the kind of extension of the diet approach, kind of more of a short term um, approach and what's going to happen over the long term”

Grace is a genuine operator with meaningful scale: 70,000 NHS patients supported, partnerships across 200+ GP practices, NHS Innovation Accelerator Fellow status, and actual product-market fit signals. She has relevant startup experience (Microsoft, Deliveroo, Scape/Facebook acquisition) and meaningful clinical credibility through NHS partnerships. However, she is not a marquee name in health tech and the episode would have benefited from deeper discussion of specific scaling mechanics or harder operational challenges.

“Having supported over 70,000 NHS patients so far, Grace's career spans operations, product and leadership, including roles at Microsoft, Deliveroo and um, Scape, which was acquired by Facebook”

“We partnered with about 200 um, or more GP practices and supported 70,000 members of the public”

The episode includes some concrete numbers (70,000 patients, 200+ GP practices, 1.8% VC funding to female founders, 1.5k swim/40k cycle/10k run in Olympic triathlon) but lacks specificity on core operational metrics: What is actual product engagement? What are real outcome improvements (blood pressure reduction is mentioned but no data)? What is cost per patient? Revenue? Churn? The VC funding stat (1.8% to all-female teams) is cited but not contextualized to Holly's own fundraising decisions. Most claims about impact are stated assertively without numbers.

“We partnered with about 200 um, or more GP practices and supported 70,000 members of the public”

“at uh, the moment I think it's 1.8% of VC funds uh, in the UK goes to fully female founded teams”

Catherine Davies asks reasonable setup questions and demonstrates genuine curiosity, but rarely pushes back or probe deeper into tensions or specifics. She accepts Grace's framing of NHS adoption as inevitable success and doesn't interrogate the 'many more years than we wanted' timeline - what were concrete delays? Why? She doesn't ask about unit economics, retention, or concrete competitive positioning. The conversation is warm and encouraging but lacks intellectual rigor; most follow-ups are gentle affirmations rather than sharp challenges.

“So you weren't tempted then to spend too long in big corporates, kind of following your parents path and then going into one of these big companies like Microsoft. That didn't appeal?”

“And do you think if people can get to that sort of change element of the three Cs that can have a significant impact on the NHS and the challenges that it's facing”